Responsiveness and clinically meaningful improvement, according to disability level, of five walking measures after rehabilitation in multiple sclerosis: a European multicenter … I Baert, J Freeman, T Smedal, U Dalgas, A Romberg, A Kalron, H Conyers, ... Neurorehabilitation and neural repair 28 (7), 621-631, 2014 | 258 | 2014 |
Muscle strength and power in persons with multiple sclerosis–a systematic review and meta-analysis MLK Jørgensen, U Dalgas, I Wens, LG Hvid Journal of the neurological sciences 376, 225-241, 2017 | 169 | 2017 |
High intensity exercise in multiple sclerosis: effects on muscle contractile characteristics and exercise capacity, a randomised controlled trial I Wens, U Dalgas, F Vandenabeele, L Grevendonk, K Verboven, ... PloS one 10 (9), e0133697, 2015 | 131 | 2015 |
Multiple sclerosis affects skeletal muscle characteristics I Wens, U Dalgas, F Vandenabeele, M Krekels, L Grevendonk, BO Eijnde PloS one 9 (9), e108158, 2014 | 121 | 2014 |
Effects of an individual 12-week community-located “start-to-run” program on physical capacity, walking, fatigue, cognitive function, brain volumes, and structures in persons … P Feys, L Moumdjian, F Van Halewyck, I Wens, BO Eijnde, ... Multiple Sclerosis Journal 25 (1), 92-103, 2019 | 109 | 2019 |
Brain derived neurotrophic factor in multiple sclerosis: effect of 24 weeks endurance and resistance training I Wens, C Keytsman, N Deckx, N Cools, U Dalgas, BO Eijnde European journal of neurology 23 (6), 1028-1035, 2016 | 107 | 2016 |
Adrenergically and non-adrenergically mediated human adipose tissue lipolysis during acute exercise and exercise training K Verboven, R Stinkens, D Hansen, I Wens, I Frederix, BO Eijnde, ... Clinical Science 132 (15), 1685-1698, 2018 | 81 | 2018 |
Tolerogenic dendritic cell-based treatment for multiple sclerosis (MS): a harmonised study protocol for two phase I clinical trials comparing intradermal and intranodal cell … B Willekens, S Presas-Rodríguez, MJ Mansilla, J Derdelinckx, WP Lee, ... BMJ open 9 (9), e030309, 2019 | 78 | 2019 |
12 weeks of combined endurance and resistance training reduces innate markers of inflammation in a randomized controlled clinical trial in patients with multiple sclerosis N Deckx, I Wens, AH Nuyts, N Hens, BY De Winter, G Koppen, ... Mediators of inflammation 2016 (1), 6789276, 2016 | 61 | 2016 |
Does multiple sclerosis affect glucose tolerance? I Wens, U Dalgas, N Deckx, N Cools, BO Eijnde Multiple Sclerosis Journal 20 (9), 1273-1276, 2014 | 52 | 2014 |
Cardiopulmonary fitness is related to disease severity in multiple sclerosis M Heine, I Wens, M Langeskov-Christensen, O Verschuren, BO Eijnde, ... Multiple Sclerosis Journal 22 (2), 231-238, 2016 | 43 | 2016 |
Muscular, cardiac, ventilatory and metabolic dysfunction in patients with multiple sclerosis: Implications for screening, clinical care and endurance and resistance exercise … I Wens, BO Eijnde, D Hansen Journal of the neurological sciences 367, 107-121, 2016 | 42 | 2016 |
Is the impact of fatigue related to walking capacity and perceived ability in persons with multiple sclerosis? A multicenter study U Dalgas, M Langeskov-Christensen, A Skjerbæk, E Jensen, I Baert, ... Journal of the neurological sciences 387, 179-186, 2018 | 41 | 2018 |
Impact of 24 weeks of resistance and endurance exercise on glucose tolerance in persons with multiple sclerosis I Wens, D Hansen, K Verboven, N Deckx, L Kosten, ALM Stevens, ... American journal of physical medicine & rehabilitation 94 (10S), 838-847, 2015 | 41 | 2015 |
High intensity aerobic and resistance exercise can improve glucose tolerance in persons with multiple sclerosis: a randomized controlled trial I Wens, U Dalgas, F Vandenabeele, K Verboven, D Hansen, N Deckx, ... American journal of physical medicine & rehabilitation 96 (3), 161-166, 2017 | 38 | 2017 |
Slowed Exercise-Onset Vo2 Kinetics During Submaximal Endurance Exercise in Subjects With Multiple Sclerosis D Hansen, I Wens, L Kosten, K Verboven, BO Eijnde Neurorehabilitation and neural repair 27 (1), 87-95, 2013 | 38 | 2013 |
Impact of high-intensity concurrent training on cardiovascular risk factors in persons with multiple sclerosis–pilot study C Keytsman, D Hansen, I Wens, B O. Eijnde Disability and Rehabilitation 41 (4), 430-435, 2019 | 31 | 2019 |
Clinical and immunological control of experimental autoimmune encephalomyelitis by tolerogenic dendritic cells loaded with MOG-encoding mRNA J Derdelinckx, MJ Mansilla, M De Laere, WP Lee, J Navarro-Barriuso, ... Journal of neuroinflammation 16, 1-20, 2019 | 28 | 2019 |
Elevated cardiovascular risk factors in multiple sclerosis C Keytsman, BO Eijnde, D Hansen, K Verboven, I Wens Multiple sclerosis and related disorders 17, 220-223, 2017 | 28 | 2017 |
Is long-term exercise intervention effective to improve cardiac autonomic control during exercise in subjects with multiple sclerosis? A randomized controlled trial. D HANSEN, I WENS, C KEYTSMAN, B OP'T EIJNDE, P DENDALE | 28 | 2015 |